2Morrow

Kirkland, WA, US

2Morrow develops smartphone-based digital therapeutic apps that use behavioral science techniques to support smoking cessation, weight loss, stress reduction, and other health goals. Its products are designed for individuals seeking help with behavior change.

Facts

HQ
Kirkland, WA, US
Sectors
Digital health, Digital therapeutics, Behavioral health, Mobile apps, Healthtech
Stage
Seed
Members see funding amounts.
.

Is this your organization? Claim it

Life Science Washington Institute’s WIN Mentoring Program Helps SafKan Health Secure FDA 510(k), Clinic Adoption, and $13M+ Funding to Scale OtoSet

Life Science Washington Institute’s Washington Innovation Network (WIN) Mentoring Program has spent a decade helping early-stage life-science companies — including Redmond-based SafKan Health — navigate regulation and fundraising, contributing to SafKan’s FDA 510(k) clearance, clinic adoption, and multiple funding rounds. SafKan’s OtoSet ear-cleaning system is FDA-cleared for clinical use, has entered hundreds of U.S. clinics, and the company aims for home-use approval and a Series B round next year.

2Morrow raises $1.5M led by WRF Capital, total funding now $2.9M to expand ACT-based digital therapeutics

Seattle-area digital therapeutics startup 2Morrow raised $1.5 million, bringing total funding to $2.9 million, to expand its smartphone-based coaching apps that use Acceptance and Commitment Therapy for smoking cessation, weight loss, stress and grief. The 11-person company, led by CEO and co-founder Jo Masterson, saw increased demand in 2020 and has partnered with Fred Hutchinson Cancer Research Center since 2013.